Our read is that coffee consumption is well-supported for longevity, though with important caveats and recommended practices.
Our read is that coffee and tea consumption are considered healthy and potentially pro-longevity, with coffee drinkers having up to a 27% lower risk of all-cause mortality, according to Rhonda Patrick and David Sinclair. Rhonda Patrick notes that each daily cup of coffee corresponds to a 0.12-year reduction in epigenetic age, and compounds in coffee induce antioxidant and repair pathways.
However, Paul Saladino raises concerns about coffee's potential negative effects, including an increased risk of gastric cancer, reactive hypoglycemia, autoimmune issues, and the presence of mold toxins, acrylamide, and pesticides. He also suggests that coffee polyphenols may not be beneficial for humans and could contribute to a 'polyphenol deficiency syndrome'.
To optimize coffee consumption for longevity, Rhonda Patrick recommends an optimal daily intake of two to four cups for enriching short-chain fatty acid producing bacteria and keeping pro-inflammatory strains in check. Bryan Johnson and Paul Saladino suggest drinking coffee 90 minutes after waking and not after 12:00 p.m. to avoid disrupting sleep architecture. Rhonda Patrick also advises against adding dairy proteins to coffee, as it can bind to antioxidants and polyphenols, slowing their absorption and potentially reducing polyphenol absorption by 20-30%.
Paul Saladino avoids coffee due to concerns about reactive hypoglycemia, autoimmune issues, pesticides, mold toxins, acrylamide, and caffeine's negative impact on insulin sensitivity. He also believes coffee polyphenols are not beneficial for humans and suggests coffee consumption is associated with an increased risk of gastric cancer. Paul Saladino also notes that polyphenolic compounds in coffee, like chlorogenic acid and caffeine, may cause chromosomal breaks, and that plant molecules like caffeic acid and chlorogenic acid in coffee may be harmful to humans. Andrew Huberman warns that stimulants like high doses of coffee can be counterproductive for learning and performance. Rhonda Patrick and Paul Saladino highlight that traditional paper drip coffee machines with plastic components can release microplastics and associated chemicals into coffee. Rhonda Patrick also cautions that consuming multiple cups of coffee daily with MCT powder or heavy cream can lead to an extra 15-20 grams of saturated fat, elevating APOB lipoproteins and increasing cardiovascular disease risk. David Sinclair advises that moderate coffee consumption should be monitored for mood effects and avoided late in the day due to its 3-7 hour half-life. Bryan Johnson suggests that cerebral lysen may provide better mental clarity than coffee or tea. Rhonda Patrick notes that adding dairy proteins to coffee can bind to its antioxidants and polyphenols, slowing their absorption and reducing polyphenol absorption by 20-30%.
The specific components in coffee responsible for its health benefits are not yet fully understood, and caffeine alone does not replicate all observed effects, according to Peter Attia. Further understanding of these components and their mechanisms could change the verdict. Additionally, more research on the long-term effects of coffee polyphenols on human health, particularly regarding Paul Saladino's concerns about 'polyphenol deficiency syndrome' and chromosomal breaks, could alter the current assessment. The safety of coffee decaffeination methods is also relevant to coffee's health benefits, as noted by Rhonda Patrick.
The effect size is large enough to matter clinically, not just statistically.
Benefits hold across the populations where it's been tested.
The effect size is large enough to matter clinically, not just statistically.
Benefits hold across the populations where it's been tested.
Mechanistic and trial evidence converge on a real, replicable effect.
Confounding and publication bias inflate the apparent benefit.
The headline effect shrinks once you account for trial quality.
Confounding and publication bias inflate the apparent benefit.
Confounding and publication bias inflate the apparent benefit.
The headline effect shrinks once you account for trial quality.